T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy

Abstract

Quantitative magnetic resonance image (MRI) in individual muscles may be useful for monitoring disease progression in Duchenne muscular dystrophy (DMD). The purpose of this study was to measure T2 relaxation time of thigh muscles in children with DMD and healthy boys, and to correlate the T2 relaxation time of muscles with the fat fraction (FF) at quantitative magnetic resonance and results of clinical assessment. Thirty-two boys with DMD and 18 healthy boys were evaluated with T2 mapping and three-point Dixon MRI. Age, body mass index (BMI), muscle strength assessment, timed functional tests (time to walk or run 10 metres, rise from the floor and ascend four stairs), and the North Star Ambulatory Assessment (NSAA) were evaluated. Spearman’s correlation was used to assess the relationships between FF and clinical assessments and T2 relaxation time. The mean T2 relaxation time of thigh muscles in DMD was significantly longer than that in the control group (P<0.05), except for the gracilis (P=0.952). The gracilis, sartorius and adductor longus were relatively spared by fatty infiltration in DMD patients. The T2 relaxation time was correlated significantly with the mean FF in all muscles. Age, BMI, total muscle strength score, timed functional tests and NSAA were significantly correlated with the overall mean T2 relaxation time. T2 mapping may prove clinically useful in monitoring muscle changes as a result of the disease process and in predicting the outcome of DMD patients.

Keywords

T2 mapping / Duchenne muscular dystrophy / skeletal muscle / fat infiltration

References

[1] BushbyK, FinkelR, BirnkrantDJ, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol, 2010, 9(1): 77-93

[2] HoffmanE B R Jr, KunkelLM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 1987, 51(6): 919-928

[3] McDouallRM, DunnMJ, DubowitzV. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci, 1990, 99(2–3): 199-217

[4] MoxleyR 3, AshwalS, PandyaS, et al.. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology, 2005, 64(1): 13-20

[5] SchmidtS, HafnerP, KleinA, et al.. Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross–sectional analysis. Neuromuscul Disord, 2018, 28(1): 16-23

[6] LerarioA, BonfiglioS, SormaniM, et al.. Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures. BMC Neurol, 2012, 12: 91

[7] MazzoneE, VascoG, SormaniMP, et al.. Functional changes in Duchenne muscular dystrophy: a 12–month longitudinal cohort study. Neurology, 2011, 77(3): 250-256

[8] MazzoneE, MartinelliD, BerardinelliA, et al.. North Star Ambulatory Assessment, 6–minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord, 2010, 20(11): 712-716

[9] MayhewAG, CanoSJ, ScottE, et al.. Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol, 2013, 55(11): 1046-1052

[10] KimHK, LaorT, HornPS, et al.. Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol, 2010, 11(3): 304-311

[11] GaetaM, MessinaS, MiletoA, et al.. Muscle fatfraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol, 2012, 41(8): 955-961

[12] JohnstonJH, KimHK, MerrowAC, et al.. Quantitative Skeletal Muscle MRI: Part 1, Derived T2 Fat Map in Differentiation Between Boys With Duchenne Muscular Dystrophy and Healthy Boys. AJR Am J Roentgenol, 2015, 205(2): W207-215

[13] KimHK, SeraiS, LindquistD, et al.. Quantitative Skeletal Muscle MRI: Part 2, MR Spectroscopy and T2 Relaxation Time Mapping–Comparison Between Boys With Duchenne Muscular Dystrophy and Healthy Boys. AJR Am J Roentgenol, 2015, 205(2): W216-223

[14] ReederSB, WenZF, YuHZ, et al.. Multicoil Dixon chemical species separation with an iterative leastsquares estimation method. Magn Reson Med, 2004, 51(1): 35-45

[15] HuHH, KimHW, NayakKS, et al.. Comparison of fatwater MRI and single–voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring), 2010, 18(4): 841-847

[16] AokiT, YamaguchiS, KinoshitaS, et al.. Quantification of bone marrow fat content using iterative decomposition of water and fat with echo asymmetry and least–squares estimation (IDEAL): reproducibility, site variation and correlation with age and menopause. Br J Radiol, 2016, 89(1065): 20150538

[17] HuL, ZhaYF, WangL, et al.. Quantitative Evaluation of Vertebral Microvascular Permeability and Fat Fraction in Alloxan–induced Diabetic Rabbits. Radiology, 2018, 287(1): 128-136

[18] HuangY, MajumdarS, GenantHK, et al.. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging, 1994, 4(1): 59-64

[19] FlorenceJM, PandyaS, KingWM, et al.. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther, 1992, 72(2): 115-122

[20] BrookeMH, FenichelGM, GriggsRC, et al.. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve, 1983, 6(2): 91-103

[21] McDonaldCM, AbreschRT, CarterGT, et al.. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil, 1995, 74(5Suppl): S70-92

[22] BushbyK, ConnorE. Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clin Investig (Lond), 2011, 1(9): 1217-1235

[23] MazzoneES, MessinaS, VascoG, et al.. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord, 2009, 19(7): 458-461

[24] MazzoneE, MartinelliD, BerardinelliA, et al.. North Star Ambulatory Assessment, 6–minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord, 2010, 20(11): 712-716

[25] KanHE, ScheenenTW, WohlgemuthM, et al.. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord, 2009, 19(5): 357-362

[26] WillisTA, HollingsworthKG, CoombsA, et al.. Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study. PLos One, 2013, 8(8): e70993

[27] BurakiewiczJ, SinclairCDJ, FischerD, et al.. Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy. J Neurol, 2017, 264(10): 2053-2067

[28] HooijmansMT, NiksEH, BurakiewiczJ, et al.. Nonuniform muscle fat replacement along the proximodistal axis in Duchenne muscular dystrophy. Neuromuscul Disord, 2017, 27(5): 458-464

[29] HooijmansMT, DamonBM, FroelingM, et al.. Evaluation of skeletal muscle DTI in patients with duchenne muscular dystrophy. NMR Biomed, 2015, 28(11): 1589-1597

[30] MankodiA, BishopCA, AuhS, et al.. Quantifying disease activity in fatty–infiltrated skeletal muscle by IDEAL–CPMG in Duchenne muscular dystrophy. Neuromuscul Disord, 2016, 26(10): 650-658

[31] WattjesMP, KleyRA, FischerD. Neuromuscular imaging in inherited muscle diseases. Eur Radiol, 2010, 20(10): 2447-2460

[32] ForbesSC, WillcocksRJ, TriplettWT, et al.. Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study. PLoS One, 2014, 9(9): e106435

[33] GarroodP, HollingsworthKG, EagleM, et al.. MR imaging in Duchenne muscular dystrophy: quantification of T1–weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging, 2009, 30(5): 1130-1138

[34] ArpanI, ForbesSC, LottDJ, et al.. T(2) mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross–sectional study of lower leg muscles in 5–15–yearold boys with Duchenne muscular dystrophy. NMR Biomed, 2013, 26(3): 320-328

[35] KimHK, LaorT, HornPS, et al.. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology, 2010, 255(3): 899-908

[36] ArpanI, WillcocksRJ, ForbesSC, et al.. Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology, 2014, 83(11): 974-980

[37] LiW, ZhengY, ZhangW, et al.. Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study. Neuromuscul Disord, 2015, 25(5): 375-380

[38] ZhengYM, LiW, DuJ, et al.. The trefoil with single fruit sign in muscle magnetic resonance imaging is highly specific for dystrophinopathies. Eur J Radiol, 2015, 84(10): 1992-1998

[39] PolavarapuK, ManjunathM, Preethish–KumarV, et al.. Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern. Neuromuscul Disord, 2016, 26(11): 768-774

[40] WokkeBH, Van Den BergenJC, HooijmansMT, et al.. T2 relaxation times are increased in skeletal muscle of DMD but not BMD patients. Muscle Nerve, 2016, 53(1): 38-43

[41] GaudreaultN, GravelD, NadeauS, et al.. Gait patterns comparison of children with Duchenne muscular dystrophy to those of control subjects considering the effect of gait velocity. Gait Posture, 2010, 32(3): 342-347

[42] DoglioL, PavanE, PernigottiI, et al.. Early signs of gait deviation in Duchenne muscular dystrophy. Eur J Phys Rehabil Med, 2011, 47(4): 587-594

[43] GaneaR, JeannetPY, Paraschiv–IonescuA, et al.. Gait assessment in children with Duchenne muscular dystrophy during long–distance walking. J Child Neurol, 2012, 27(1): 30-38

[44] CarlierPG. Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology, different information and different implications. Neuromuscul Disord, 2014, 24(5): 390-392

[45] BendixenRM, LottDJ, SenesacC, et al.. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy. Disabil Rehabil, 2014, 36(22): 1918-1923

[46] FischerD, HafnerP, RubinoD, et al.. The 6–minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A crosssectional study. Neuromuscul Disord, 2016, 26(7): 414-422

[47] JohnstonJH, KimHK, MerrowAC, et al.. Quantitative Skeletal Muscle MRI: Part I, Derived T2 Fat Map in Differentiation Between Boys With Duchenne Muscular Dystrophy and Healthy Boys. Am J Roentgenol, 2015, 205(2): W207-W214

[48] MankodiA, AzzabouN, BuleaT, et al.. Skeletal muscle water T–2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy. Neuromuscul Disord, 2017, 27(8): 705-714

[49] PattenC, MeyerRA, FleckensteinJL. T2 mapping of muscle. Semin Musculoskelet Radiol, 2003, 7(4): 297-305